US net drug spending surged 11.4% last year, boosted by obesity and oncology meds: IQVIA
Last year's $50 billion increase in net drug spending marked a period of "historic growth" that was only surpassed by 2021's COVID-19 vaccine launches, according to a new report from life sciences intelligence firm IQVIA.
Last year's $50 billion increase in net drug spending marked a period of "historic growth" that was only surpassed by 2021's COVID-19 vaccine launches, according to a new report from life sciences intelligence firm IQVIA.
